is sweating a side effect of semaglutide Ozempic: GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Common GLP-1 Semaglutide Side Effects

Our team will keep watching the participants in the study for five years

After reviewing the evidence, the European Medicines Agency recommended updating the product information for semaglutide medicines Ozempic, Rybelsus and Wegovy to list NAION as a side effect classified as very rare , and the World Health Organization issued a safety alert in June 2025

marketed for diabetes as Mounjaro and for weight management under trade names such as Zepbound) Tirzepatide combines GLP-1 and GIP receptor agonism and has shown the largest average weight losses of any medication to date

Novo Nordisk has been investigating CagriSema through the REDEFINE programme, a series of Phase 3 clinical trials in adults with overweight or obesity